High- versus low-dose levo-leucovorin as a modulator of 5-fluorouracil in advanced colorectal cancer: A ‘GISCAD’ phase III study
- 1 February 1997
- journal article
- clinical trial
- Published by Elsevier in Annals of Oncology
- Vol. 8 (2) , 169-174
- https://doi.org/10.1023/a:1008200713533
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Two consecutive phase II studies of oxaliplatin (L-OHP) for treatment of patients with advanced colorectal carcinoma who were resistant to previous treatment with fluoropyrimidinesAnnals of Oncology, 1996
- Phase II trial of 5-fluorouracil and the natural l isomer of folinic acid in the treatment of advanced colorectal carcinomaEuropean Journal Of Cancer, 1994
- Chemotherapy for Colorectal CancerNew England Journal of Medicine, 1994
- Folinic acid and 5-fluorouracil as adjuvant chemotherapy in colon cancerGastroenterology, 1994
- The benefit of leucovorin-modulated fluorouracil as postoperative adjuvant therapy for primary colon cancer: results from National Surgical Adjuvant Breast and Bowel Project protocol C-03.Journal of Clinical Oncology, 1993
- The Current Status of Camptothecin Analogues as Antitumor AgentsJNCI Journal of the National Cancer Institute, 1993
- Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: evidence in terms of response rate. Advanced Colorectal Cancer Meta-Analysis Project.Journal of Clinical Oncology, 1992
- Reporting results of cancer treatmentCancer, 1981
- Efficacy of adjuvant fluorouracil and folinic acid in colon cancer: International Multicentre Pooled Analysis of Colon Cancer Trials (IMPACT) investigatorsPublished by Elsevier
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958